Evidence map›Paper›PMID 40190542›Full record

ArticleAfrican health sciences2024

Sero-prevalence of Hepatitis B and C at a Primary Health Care Facility in Ghana.

Madison Adanusa, George Adjei, Sebastian Eliason, Samuel Amoah, Benson Cecil, Ignatius Sirikyi, Faustina Pappoe, Anasthasia Ofori, Frederick Adjei, Bernice Appau and 3 more

Abstract read
In one paragraph

Article in African health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Madison AdanusaUniversity of Cape Coast, Directorate of University Health Services.
George AdjeiUniversity of Cape Coast School of Medical Sciences, Department of Community Medicine.
Sebastian EliasonUniversity of Cape Coast School of Medical Sciences, School of Medical Sciences, Department of Community Medicine.
Samuel AmoahUniversity of Cape Coast, Directorate of University Health Services.
Benson CecilUniversity of Cape Coast, Directorate of University Health Services.
Ignatius SirikyiUniversity of Cape Coast, Directorate of University Health Services.
Faustina PappoeUniversity of Cape Coast, Directorate of University Health Services.
Anasthasia OforiUniversity of Cape Coast School of Medical Sciences, Department of Immunology and Microbiology.
Frederick AdjeiUniversity of Cape Coast School of Nursing and Midwifery.
Bernice AppauUniversity of Cape Coast, Directorate of University Health Services.
Benjamin NyaneUniversity of Cape Coast, Directorate of University Health Services.
Arthur RudolfUniversity of Cape Coast, Directorate of University Health Services.
Hagan OhenebaUniversity of Cape Coast School of Medical Sciences, Department of Medical Biochemistry.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The advent of emerging global infections such as SARS-CoV-2 has brought forth the public health crises of neglected diseases in the LMICs. Viral hepatitis infections remain a public health problem especially in the advent of emerging. Viral hepatitis which preponderantly afflicts citizens of LMICs is one such group of diseases which exerts considerable burden in these countries, especially, hepatitis B and C. There is an effective vaccine against Hepatitis B and curative treatment to hepatitis C, however, access has been hampered resulting in deleterious sequalae. Identifying population afflicted by these infections could lead to prevention of the complications. Materials and Methods: Retrospective review of electronic data on individuals screened for hepatitis B and C at the University of Cape Coast Hospital were abstracted. Data abstracted included hepatitis B and C test status, age, sex, previous immunisation history and region of residence. Overall prevalence and prevalence in different categories were calculated. Results: Data for 6,006 were collected and used for the analyses. The overall prevalence for hepatitis B in the study group was 5.06%. The prevalence for hepatitis C was 0.93%. Conclusion: The burden of hepatitis B and C infection in Ghana is still high.

Indexed as

Hepatitis BHepatitis CPrimary Health CareAdolescentAdultAgedChildChild, PreschoolCOVID-19FemaleGhanaHumansMaleMiddle AgedPrevalenceRetrospective StudiesGhanaHepatitis B and CPrimary Health Care Facility

Identifiers

PMID40190542
PMCPMC11970139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.